| Dr Sue A Fessler, MD | |
|
350 Heritage Way Ste 2100, Kalispell, MT 59901-3167 | |
| (406) 257-8992 | |
| (406) 257-8996 |
| Full Name | Dr Sue A Fessler |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 29 Years |
| Location | 350 Heritage Way Ste 2100, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174512636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 90139 (Montana) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 90139 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| North Valley Hospital | Whitefish, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Independence Blue Cross (IBC) has reached a significant milestone with 100 primary care practices with more than 1,000 physicians now qualified as "patient-centered medical homes," and announced today that it is stepping up its efforts to support this transformation of primary care.
S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.
A protein that activates estrogen receptors in breast cancer may play a role in resistance to therapeutic effects of anti-estrogen tamoxifen treatment, according to a study in the Journal of the National Cancer Institute.
New research based on the internal documents of one of the world's biggest tobacco companies, British American Tobacco (BAT), suggests that it been complicit in the smuggling of tobacco into China and has benefited from this illicit trade.
› Verified 8 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Independence Blue Cross (IBC) has reached a significant milestone with 100 primary care practices with more than 1,000 physicians now qualified as "patient-centered medical homes," and announced today that it is stepping up its efforts to support this transformation of primary care.
S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.
A protein that activates estrogen receptors in breast cancer may play a role in resistance to therapeutic effects of anti-estrogen tamoxifen treatment, according to a study in the Journal of the National Cancer Institute.
New research based on the internal documents of one of the world's biggest tobacco companies, British American Tobacco (BAT), suggests that it been complicit in the smuggling of tobacco into China and has benefited from this illicit trade.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sue A Fessler, MD 350 Heritage Way Ste 2100, Kalispell, MT 59901-3167 Ph: (406) 257-8992 | Dr Sue A Fessler, MD 350 Heritage Way Ste 2100, Kalispell, MT 59901-3167 Ph: (406) 257-8992 |
News Archive
Independence Blue Cross (IBC) has reached a significant milestone with 100 primary care practices with more than 1,000 physicians now qualified as "patient-centered medical homes," and announced today that it is stepping up its efforts to support this transformation of primary care.
S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.
A protein that activates estrogen receptors in breast cancer may play a role in resistance to therapeutic effects of anti-estrogen tamoxifen treatment, according to a study in the Journal of the National Cancer Institute.
New research based on the internal documents of one of the world's biggest tobacco companies, British American Tobacco (BAT), suggests that it been complicit in the smuggling of tobacco into China and has benefited from this illicit trade.
› Verified 8 days ago
Dr. Tobin James Hoppes, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Claremont St Ste H, Kalispell, MT 59901 Phone: 406-752-7406 Fax: 406-752-7544 | |
Marise K Johnson, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1280 Burns Way, Kalispell, MT 59901 Phone: 406-755-5266 Fax: 406-755-0228 | |
Kerry J Eby, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-6725 | |
Dr. Jeffrey W. Watkins, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 350 Heritage Way Ste 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-275-8996 | |
Torbjorn Ingvar Joreteg, MD PHD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 160 Heritage Way, Kalispell, MT 59901 Phone: 406-755-7785 Fax: 406-755-7857 | |
Nathaniel Lyle Hall, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-751-4161 | |
Anna Rose Robbins, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 310 Sunnyview Ln, Northwest Hospitalists, Kalispell, MT 59901 Phone: 406-751-5310 Fax: 406-751-5769 |